Patents by Inventor Catherine Herry

Catherine Herry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11872306
    Abstract: The present invention relates to granules of active ingredient with double taste masking, wherein the double taste masking is achieved by a hot-melt compound selected from waxes, hydrogenated vegetable oils, fatty acids, mono-, di- and triesters of fatty acids and of glycerol, triglycerides, glycerides, polyoxylglycerides, fatty alcohols, and mixtures thereof, and a thermoplastic polymer that is soluble at a pH less than or equal to 5. The invention also relates to the method for producing these granules and to orodispersible tablets containing these coated granules.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: January 16, 2024
    Assignee: Ethypharm
    Inventors: Catherine Herry, Caroline Ailhas
  • Publication number: 20230301927
    Abstract: The present invention relates to a process for preparing an orally administered pharmaceutical composition with colonic delivery, comprising at least one core and a coating layer, making it possible to obtain a pharmaceutical composition which exhibits uniform and reproducible dissolution and therefore likewise uniform and reproducible release of the active ingredient with low coefficients of variation, said process being characterized in that it comprises the following steps: a) Spraying onto a neutral support an aqueous suspension comprising at least one anionic (meth)acrylate copolymer that is soluble at a pH greater than 5.5 and at least one active ingredient intended to be delivered in the colon; or a?) Spraying onto a neutral support an aqueous suspension comprising at least one anionic (meth)acrylate copolymer that is soluble at a pH greater than 5.
    Type: Application
    Filed: November 13, 2020
    Publication date: September 28, 2023
    Inventors: Catherine HERRY, Yuqiu ZHU, Bruno CRIERE
  • Patent number: 10987309
    Abstract: The invention relates to an oral pharmaceutical composition in the form of a sustained-release tablet comprising an active ingredient capable of being misused, which composition makes it possible to combat misuse by injection.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: April 27, 2021
    Assignee: ETHYPHARM
    Inventors: Catherine Herry, Pauline Contamin
  • Publication number: 20190125663
    Abstract: The present invention relates to granules of active ingredient with double taste masking, wherein the double taste masking is achieved by a hot-melt compound selected from waxes, hydrogenated vegetable oils, fatty acids, mono-, di- and triesters of fatty acids and of glycerol, triglycerides, glycerides, polyoxylglycerides, fatty alcohols, and mixtures thereof, and a thermoplastic polymer that is soluble at a pH less than or equal to 5. The invention also relates to the method for producing these granules and to orodispersible tablets containing these coated granules.
    Type: Application
    Filed: October 30, 2015
    Publication date: May 2, 2019
    Applicant: Ethypharm
    Inventors: Catherine Herry, Caroline Ailhas
  • Patent number: 10258692
    Abstract: The present invention concerns an oral pharmaceutical formulation made from a microemulsion between an aqueous solution comprising at least one BCS (Biopharmaceutics Classification System) class III active principle and one oily phase comprising an oily vehicle that is self-emulsifiable on contact with water.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: April 16, 2019
    Assignee: ETHYPHARM
    Inventors: Caroline Ailhas, Catherine Herry
  • Patent number: 10111869
    Abstract: The present invention relates to the use of a sustained release matrix containing at least one opioid for producing a solid oral formulation in table form suitable for reducing blood concentration fluctuations of said opioid.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: October 30, 2018
    Assignee: ETHYPHARM
    Inventors: Catherine Herry, Maryline Boyer, Francoise Vauzelle-Kervroedan, Pascal Oury
  • Patent number: 9877925
    Abstract: A sustained release oral pharmaceutical form suitable for single daily dose administration has a neutral microgranule coated with a mounting layer of active ingredient and pharmaceutically acceptable binder; and a coating layer of a hydrophobic coating polymer of a non-water soluble cellulose derivative, and at least 20% of inert load in relation to dry weight of hydrophobic coating polymer. The pharmaceutical form has improved resistance to rapid release of active ingredient, particularly in the presence of alcohol.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: January 30, 2018
    Assignee: ETHYPHARM
    Inventors: Catherine Herry, Laury Trichard
  • Patent number: 9603797
    Abstract: The present invention relates to an oral and/or buccal composition in the form of a thin film of a pharmaceutically active ingredient weakly soluble in water and gastro-intestinal tract fluids, comprising particles of said active ingredient dispersed in a film-forming polymer, at least 50% by weight of the total weight of the active ingredient having a particle size distribution such that at least 90% of said particles have a size below 1000 nm, preferably less than 800 nm, and even more preferably less than 600 nm, and to the method of preparing that composition and the use thereof.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: March 28, 2017
    Assignee: ETHYPHARM
    Inventors: Catherine Herry, Vincent Billoet, Pascal Oury
  • Publication number: 20170065531
    Abstract: A sustained release oral pharmaceutical form suitable for single daily dose administration has a neutral microgranule coated with a mounting layer of active ingredient and pharmaceutically acceptable binder; and a coating layer of a hydrophobic coating polymer of a non-water soluble cellulose derivative, and at least 20% of inert load in relation to dry weight of hydrophobic coating polymer. The pharmaceutical form has improved resistance to rapid release of active ingredient, particularly in the presence of alcohol.
    Type: Application
    Filed: March 11, 2015
    Publication date: March 9, 2017
    Inventors: Catherine HERRY, Laury Trichard
  • Publication number: 20170016925
    Abstract: A pharmaceutical form for combating chemical submission includes an active ingredient and at least one compound which enables immediate modification of the organoleptic characteristics of a beverage into which the pharmaceutical form is introduced. The compound is selected from the group consisting of an opacifier, a fluorescent agent, floating particles, particles that are perceptible in the mouth, effervescent microgranules, and mixtures thereof.
    Type: Application
    Filed: September 30, 2016
    Publication date: January 19, 2017
    Applicant: ETHYPHARM
    Inventors: CATHERINE HERRY, PAULINE CONTAMIN, EMMANUEL DUPAU
  • Patent number: 9492397
    Abstract: Oral pharmaceutical form containing microgranules for the sustained release of at least one active principle, including a neutral carrier that is insoluble in water or in an alcohol solution, or a neutral carrier rendered insoluble in water or an alcohol solution, comprising at least one first mounting layer containing at least one active principle and optionally a pharmaceutically acceptable binding agent, wherein the whole comprises at least one coating based on at least one hydrophobic polymer.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: November 15, 2016
    Assignee: ETHYPHARM
    Inventors: Catherine Herry, Laury Trichard-Trolet
  • Publication number: 20160310434
    Abstract: The invention relates to a pharmaceutical matrix tablet which can be administered orally once or twice per day with gastro-retentive controlled release of Baclofen.
    Type: Application
    Filed: December 18, 2014
    Publication date: October 27, 2016
    Applicant: ETHYPHARM
    Inventors: CATHERINE HERRY, PAULINE CONTAMIN
  • Publication number: 20150359735
    Abstract: The present invention relates to an oral and/or buccal composition in the form of a thin film of a pharmaceutically active ingredient weakly soluble in water and gastro-intestinal tract fluids, comprising particles of said active ingredient dispersed in a film-forming polymer, at least 50% by weight of the total weight of the active ingredient having a particle size distribution such that at least 90% of said particles have a size below 1000 nm, preferably less than 800 nm, and even more preferably less than 600 nm, and to the method of preparing that composition and the use thereof.
    Type: Application
    Filed: December 9, 2013
    Publication date: December 17, 2015
    Applicant: ETHYPHARM
    Inventors: Catherine HERRY, Vincent BILLOET, Pascal OURY
  • Publication number: 20150250737
    Abstract: A sustained release oral pharmaceutical form suitable for single daily dose administration has a neutral microgranule coated with a mounting layer of active ingredient and pharmaceutically acceptable binder; and a coating layer of a hydrophobic coating polymer of a non-water soluble cellulose derivative, and at least 20% of inert load in relation to dry weight of hydrophobic coating polymer. The pharmaceutical form has improved resistance to rapid release of active ingredient, particularly in the presence of alcohol.
    Type: Application
    Filed: March 11, 2015
    Publication date: September 10, 2015
    Inventors: Catherine HERRY, Laury Trichard
  • Publication number: 20150246035
    Abstract: Water-insoluble matrix tablets which are capable of prolonged release of active principles liable to be diverted for drug addiction purposes, the said active principles being dispersed within a tabletting matrix composed of at least one excipient selected from the group consisting of pH-independent, water-insoluble delay polymers, inorganic excipients and mixtures thereof, and exhibiting a crush resistance of at least 4 MPa.
    Type: Application
    Filed: April 29, 2015
    Publication date: September 3, 2015
    Applicant: ETHYPHARM SA
    Inventors: Vincent CAILLY-DUFESTEL, Catherine HERRY, Johnatan BACON, Pascal OURY
  • Publication number: 20150165032
    Abstract: The present invention concerns an oral pharmaceutical formulation made from a microemulsion between an aqueous solution comprising at least one BCS (Biopharmaceutics Classification System) class III active principle and one oily phase comprising an oily vehicle that is self-emulsifiable on contact with water.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 18, 2015
    Inventors: Caroline Ailhas, Catherine Herry
  • Publication number: 20140322321
    Abstract: The invention relates to an oral pharmaceutical composition in the form of a sustained-release tablet comprising an active ingredient capable of being misused, which composition makes it possible to combat misuse by injection.
    Type: Application
    Filed: December 6, 2012
    Publication date: October 30, 2014
    Applicant: ETHYPHARM
    Inventors: Catherine Herry, Pauline Contamin
  • Publication number: 20140255480
    Abstract: The invention relates to a pharmaceutical formulation of nanonised fenofibrate, to a method for preparing same, and to the uses thereof.
    Type: Application
    Filed: April 7, 2014
    Publication date: September 11, 2014
    Applicant: ETHYPHARM
    Inventors: Catherine HERRY, Pascal OURY
  • Publication number: 20140220127
    Abstract: The present invention relates to the use of a sustained release matrix containing at least one opioid for producing a solid oral formulation in table form suitable for reducing blood concentration fluctuations of said opioid.
    Type: Application
    Filed: April 11, 2014
    Publication date: August 7, 2014
    Applicant: ETHYPHARM
    Inventors: Catherine HERRY, Maryline BOYER, Francoise VAUZELLE-KERVROEDAN, Pascal OURY
  • Patent number: 8709479
    Abstract: The present invention relates to a fentanyl coated tablet and to the method for the preparation thereof.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: April 29, 2014
    Assignee: Ethypharm
    Inventors: Pascal Oury, Guillaume Benoist, Catherine Herry, Joseph Duvochel